Kura
Kura Oncology
Quick answer
Kura is a pharma company (KURA) headquartered in SAN DIEGO, CA, USA with 21 tracked pipeline programs.
Pipeline (21)
Ziftomenib
Acute Myeloid Leukemia (AML)
1 trials projectCytarabine
Acute Myeloid Leukemia
1 trials projectDexamethasone
Lymphoblastic Leukemia
1 trials projectTipifarnib
Relapsed or Refractory Peripheral T-Cell Lymphoma
1 trials projectTipifarnib
HNSCC
1 trials projectTipifarnib
HRAS Gene Mutation
1 trials projectTipifarnib
Leukemia, Myelomonocytic, Chronic
1 trials projectTipifarnib
Myelodysplastic Syndromes
1 trials projectTipifarnib
Thyroid Cancer
1 trials projectZiftomenib
Advanced Malignant Neoplasm
1 trials projectDarlifarnib
Solid Tumors With HRAS Alterations
1 trials projectKO-947
Advanced Malignant Neoplasm
1 trials projectTipifarnib
NSCLC
1 trials projectTipifarnib
Advanced Solid Tumor
1 trials projectVenetoclax
Acute Myeloid Leukemia
1 trials projectZiftomenib
Relapsed/Refractory KMT2A-r Acute Leukemia
1 trials projectZiftomenib
Refractory Acute Leukemia
1 trials projectZiftomenib
AML
1 trials projectZiftomenib
Acute Myeloid Leukemia
1 trials projectZiftomenib
KMT2A-rearranged
1 trials projectziftomenib
Gastrointestinal Stromal Tumor (GIST)
1 trialsDrugs (1)
Patents (8)
US 12410184
Crystalline forms of a menin inhibitor
patentUS 12377026
Dental adhesive material kit
patentUS 12358210
Resin composition for stereolithography
patentUS 12344691
Resin composition for stereolithography
patentUS 12214061
Adhesive composition for dental use
patentUS 12208148
Dental restorative curable composition
patentUS 12145888
Zirconia molded body and pre-sintered body capable of being sintered in short ti
patentUS 12138325
Dental composition